1
1538 acknowledges that smoking prevalence may be influenced by the price and availability of tobacco, as well as awareness of the risks of smoking, and notes that a proposed directive to harmonise tobacco taxation within the EC would reduce the level of taxation in the UK and probably raise the level of consumption. The report also includes worked examples on four other priority areas already studied-alcohol-related harm, birth control, surveillance and control of infectious disease (childhood immunisation, sexually transmitted diseases, foodbome illness), and disability in the elderly. There is a need, says the report, for large-scale longitudinal studies of alcohol consumption and for information on waiting times for hospital-based family-planning services. A reduction in the number of beds for stroke patients (15 per 10 000 population, compared with 17.4 at present) could be achieved, says the report, by developing community facilities (such as physiotherapy) and by the simple preventive measure of asking general practitioners to monitor patients’ blood pressure. A second report, to be published next year, will present more detailed evidence of the effectiveness of specific interventions. 1. UK levels of health. Faculty of Public Health Medicine, 4 St Andrew’s Place, London NW1 4LB. £5.90. Junior doctors’ hours An agreement between the Government, the medical Royal Colleges, and the British Medical Association, announced last week, aims to cut the number of hours worked by junior doctors and improve their living and working conditions. Introducing the changes, the Secretary of State for Health, William Waldegrave, said that the maximum number of hours worked would be reduced "as soon as practicable" to 83 per week on average. By the end of 1994 junior doctors in the busiest jobs would be working a maximum of 72 hours per week. Some higher specialist trainees will be allowed to work more than 72 hours if it would benefit their training and if they wish to do so. The Government is making available 12-4 million to fund 200 new consultant and 50 staff-grade posts in England to achieve these reductions. Between 429 000 and ;[441000 was allocated to each regional health board last month to enable them to start making the necessary appointments. The agreement will limit maximum periods of continuous duty and minimum time off, bringing to an end the 80-hour weekend. Junior doctors’ salaries will be protected when they change contracts, despite a reduction in hours worked. A basic rate of pay will apply to the first 40 hours worked (in a full-time training post), with appropriate extra payment for additional hours. The new agreement will introduce more flexible working patterns, based on full shifts (in which the junior doctor will work continuously for no more than 10, or at weekends 13, hours) and partial shifts (less intensive work, maximum 13-16 hours). The proposed arrangements also provide for greater use of cross-over cover between junior doctors in different disciplines. Recommendations for team-based methods of working are directed at consultants, who will lead the teams. However, the Central Consultants and Specialists Committee of the BMA points out that the problem of excessive hours should not be transferred from trainees to consultants. Mr Waldegrave called on health authorities to tackle the poor living and working conditions of many junior doctors. Guidance issued by the National Health Service Management Executive states that on-call rooms "should not be regarded as second-class accommodation". The Royal Colleges and universities can withdraw educational approval from posts where accommodation does not meet acceptable standards. Health authorities have received guidance on the roles and responsibilities of the regional task forces set up to implement the reduction in working hours. The task forces are expected to report, by the end of 1993, on the implications of reducing hours in all posts to 72 hours a week by the end of 1996. Diabetic mice (and men) Gene mapping has revealed extensive homology between the human and mouse genomes-all genes so far mapped on human chromosome 17, for instance, have homologues on mouse chromosome 11. So the identification of two murine genes that influence the onset of autoimmune type I diabetes mellitus, reported in Nature last week/ has given rise to well-founded speculation that homologous genes will be found in man-one on chromosome 17, the other possibly on chromosome 1 or 4. Susceptibility to type I diabetes clearly has a large environmental component, since identical twins of affected subjects have only a 36% chance of manifesting the disease. The disorder also appears to be polygenic, for predisposition is already known to be associated with three major histocompatibility complex (MHC) class II genes, HLA-DQAJ, DQBJ, and DRBJ, on chromosome 6. The insulin gene region on chromosome 11 is also associated with susceptibility to the disease. How many genes affect diabetes susceptibility and how many different combinations of genes produce the same clinical phenotype has not been reliably estimated. A murine diabetes susceptibility gene, Idd-1, has already been located in the MHC region on chromosome 17 of non-obese diabetic (NOD) mice, but Idd-3 and Idd-4, the genes identified by Todd et al,l lie on chromosomes 3 and 11, respectively, suggesting that susceptibility to murine type I diabetes is under the control of at least three unlinked loci. A further mouse gene, Idd-2 on chromosome 9, also appears to influence susceptibility to diabetes in back-crosses between NOD mice and NOD x NON (diabetes resistant) hybrids. The observations of Todd’s group also give some indication of the complexity of the genetic control of diabetes: Idd-3 3 but not Idd4 is associated with insulitis, and Idd-4 but not Idd-3 is seen only in association with diabetes of very early onset. 1. Todd JA, Aitman TJ, Cornall RJ, et al. Genetic analysis of autoimmune type I diabetes mellitus in mice. Nature 1991; 351: 542-47. Abnormal genes, prevalent diseases In sponsoring a conference on the Molecular Genetics of Common Diseases the newly formed Caledonian Research Foundation and the more venerable Royal Society of Edinburgh seemed to be recognising a dilemma, a frustration even. Haemoglobinopathies apart, the clinical applications of molecular genetics have tended to be in rare diseases. The foci in Edinburgh on June 13 and 14 included cancer, hypertension, heart disease, and diabetes. What cancer research groups are beginning to achieve is a recognition of the molecular steps (hits) that parallel the classical pathologist’s view of the road from normal cell to malignant state. In these sequences p53 proved to be a frequent participant: in Princeton shortly this tumour suppressor protein will be wholly unavoidable, since a whole workshop is to be devoted to it. E. R. Fearon (Baltimore) discussed six gene changes in colorectal cancer; in any one tumour just three or four might be found, but in some none at all. The changes included 17p losses, right in the "hot spot" region of p53 mutations, late in the sequence; 18q losses in 75% of tumours, perhaps earlier than 17p; and the 5q abnormalities now recognised in familial adenomatosis coli. D. Lane (Dundee) found that 75 % of a mixed bag of malignant tissues stained with anti-p53. The frequency was especially high in melanoma and in gastric cancer, where p53 proved to carry a prognostic message. The session on genetic predisposition to common cancers naturally focused on "cancer families". These tragic pedigrees are rare, and the light they throw on the individually common cancers that make up the Li-Fraumeni syndrome, for example, is dim so far. Faced with a 4-year-old child with a p53 mutation who is from one such family but is cancer-free, what do you do, asked F. P. Li (Boston). In his group there was a moratorium on testing presymptomatically until the many issues had been resolved. The colon, when involved in risk families, is at least accessible; but what about non-colonic sites (desmoid tumours, biliary tumours), asked C. M. Steel (Edinburgh). Families did like to know, he claimed: their doctors might previously have dismissed the very idea of the cancer-prone

Junior doctors' hours

  • Upload
    hildred

  • View
    212

  • Download
    0

Embed Size (px)

Citation preview

1538

acknowledges that smoking prevalence may be influenced by theprice and availability of tobacco, as well as awareness of the risks ofsmoking, and notes that a proposed directive to harmonise tobaccotaxation within the EC would reduce the level of taxation in the UKand probably raise the level of consumption.The report also includes worked examples on four other priority

areas already studied-alcohol-related harm, birth control,surveillance and control of infectious disease (childhoodimmunisation, sexually transmitted diseases, foodbome illness),and disability in the elderly. There is a need, says the report, forlarge-scale longitudinal studies of alcohol consumption and forinformation on waiting times for hospital-based family-planningservices. A reduction in the number of beds for stroke patients (15per 10 000 population, compared with 17.4 at present) could beachieved, says the report, by developing community facilities (suchas physiotherapy) and by the simple preventive measure of askinggeneral practitioners to monitor patients’ blood pressure.A second report, to be published next year, will present more

detailed evidence of the effectiveness of specific interventions.

1. UK levels of health. Faculty of Public Health Medicine, 4 St Andrew’s Place, LondonNW1 4LB. £5.90.

Junior doctors’ hours

An agreement between the Government, the medical RoyalColleges, and the British Medical Association, announced last week,aims to cut the number of hours worked by junior doctors andimprove their living and working conditions. Introducing thechanges, the Secretary of State for Health, William Waldegrave,said that the maximum number of hours worked would be reduced"as soon as practicable" to 83 per week on average. By the end of1994 junior doctors in the busiest jobs would be working amaximum of 72 hours per week. Some higher specialist trainees willbe allowed to work more than 72 hours if it would benefit their

training and if they wish to do so.The Government is making available 12-4 million to fund 200

new consultant and 50 staff-grade posts in England to achieve thesereductions. Between 429 000 and ;[441000 was allocated to eachregional health board last month to enable them to start making thenecessary appointments.The agreement will limit maximum periods of continuous duty

and minimum time off, bringing to an end the 80-hour weekend.Junior doctors’ salaries will be protected when they changecontracts, despite a reduction in hours worked. A basic rate of paywill apply to the first 40 hours worked (in a full-time training post),with appropriate extra payment for additional hours.The new agreement will introduce more flexible working

patterns, based on full shifts (in which the junior doctor will workcontinuously for no more than 10, or at weekends 13, hours) andpartial shifts (less intensive work, maximum 13-16 hours). Theproposed arrangements also provide for greater use of cross-overcover between junior doctors in different disciplines.Recommendations for team-based methods of working are directedat consultants, who will lead the teams. However, the CentralConsultants and Specialists Committee of the BMA points out thatthe problem of excessive hours should not be transferred fromtrainees to consultants.Mr Waldegrave called on health authorities to tackle the poor

living and working conditions of many junior doctors. Guidanceissued by the National Health Service Management Executivestates that on-call rooms "should not be regarded as second-classaccommodation". The Royal Colleges and universities can

withdraw educational approval from posts where accommodationdoes not meet acceptable standards.

Health authorities have received guidance on the roles andresponsibilities of the regional task forces set up to implement thereduction in working hours. The task forces are expected to report,by the end of 1993, on the implications of reducing hours in all poststo 72 hours a week by the end of 1996.

Diabetic mice (and men)Gene mapping has revealed extensive homology between the

human and mouse genomes-all genes so far mapped on humanchromosome 17, for instance, have homologues on mouse

chromosome 11. So the identification of two murine genes thatinfluence the onset of autoimmune type I diabetes mellitus,reported in Nature last week/ has given rise to well-foundedspeculation that homologous genes will be found in man-one onchromosome 17, the other possibly on chromosome 1 or 4.

Susceptibility to type I diabetes clearly has a large environmentalcomponent, since identical twins of affected subjects have only a36% chance of manifesting the disease. The disorder also appears tobe polygenic, for predisposition is already known to be associatedwith three major histocompatibility complex (MHC) class II genes,HLA-DQAJ, DQBJ, and DRBJ, on chromosome 6. The insulingene region on chromosome 11 is also associated with susceptibilityto the disease. How many genes affect diabetes susceptibility andhow many different combinations of genes produce the sameclinical phenotype has not been reliably estimated.A murine diabetes susceptibility gene, Idd-1, has already been

located in the MHC region on chromosome 17 of non-obesediabetic (NOD) mice, but Idd-3 and Idd-4, the genes identified byTodd et al,l lie on chromosomes 3 and 11, respectively, suggestingthat susceptibility to murine type I diabetes is under the control of atleast three unlinked loci. A further mouse gene, Idd-2 onchromosome 9, also appears to influence susceptibility to diabetes inback-crosses between NOD mice and NOD x NON (diabetesresistant) hybrids. The observations of Todd’s group also give someindication of the complexity of the genetic control of diabetes: Idd-3 3but not Idd4 is associated with insulitis, and Idd-4 but not Idd-3 isseen only in association with diabetes of very early onset.

1. Todd JA, Aitman TJ, Cornall RJ, et al. Genetic analysis of autoimmune type Idiabetes mellitus in mice. Nature 1991; 351: 542-47.

Abnormal genes, prevalent diseases

In sponsoring a conference on the Molecular Genetics ofCommon Diseases the newly formed Caledonian ResearchFoundation and the more venerable Royal Society of Edinburghseemed to be recognising a dilemma, a frustration even.

Haemoglobinopathies apart, the clinical applications of moleculargenetics have tended to be in rare diseases. The foci in Edinburghon June 13 and 14 included cancer, hypertension, heart disease, anddiabetes.What cancer research groups are beginning to achieve is a

recognition of the molecular steps (hits) that parallel the classicalpathologist’s view of the road from normal cell to malignant state. Inthese sequences p53 proved to be a frequent participant: inPrinceton shortly this tumour suppressor protein will be whollyunavoidable, since a whole workshop is to be devoted to it. E. R.Fearon (Baltimore) discussed six gene changes in colorectal cancer;in any one tumour just three or four might be found, but in somenone at all. The changes included 17p losses, right in the "hot spot"region of p53 mutations, late in the sequence; 18q losses in 75% oftumours, perhaps earlier than 17p; and the 5q abnormalities nowrecognised in familial adenomatosis coli. D. Lane (Dundee) foundthat 75 % of a mixed bag of malignant tissues stained with anti-p53.The frequency was especially high in melanoma and in gastriccancer, where p53 proved to carry a prognostic message. Thesession on genetic predisposition to common cancers naturallyfocused on "cancer families". These tragic pedigrees are rare, andthe light they throw on the individually common cancers that makeup the Li-Fraumeni syndrome, for example, is dim so far. Facedwith a 4-year-old child with a p53 mutation who is from one suchfamily but is cancer-free, what do you do, asked F. P. Li (Boston).In his group there was a moratorium on testing presymptomaticallyuntil the many issues had been resolved. The colon, when involvedin risk families, is at least accessible; but what about non-colonicsites (desmoid tumours, biliary tumours), asked C. M. Steel

(Edinburgh). Families did like to know, he claimed: their doctorsmight previously have dismissed the very idea of the cancer-prone